---
title: "DC 7715 - Non-Hodgkin's lymphoma:"
diagnostic_code: "7715"
body_system: "Hemic and Lymphatic Systems"
cfr_section: "§ 4.117"
canonical: "https://veteranai.co/va-rating-schedule/hemic-and-lymphatic/7715-non-hodgkins-lymphoma"
source: "https://www.ecfr.gov/current/title-38/section-4.117"
updated: "2026-07-21T21:09:12.752348Z"
---

# DC 7715 - Non-Hodgkin's lymphoma:

Rated under § 4.117. Body system: Hemic and Lymphatic Systems.

## Rating criteria

| Rating | Criteria |
| --- | --- |
| 100% | When there is active disease, during treatment phase, or with indolent and non-contiguous phase of low grade NHL |

## Notes

- Note: A 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Two years after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no recurrence, rate on residuals under the appropriate diagnostic code(s)

# Non-Hodgkin's Lymphoma — VA Disability Rating (Diagnostic Code 7715)

**Body System:** Hemic and Lymphatic Systems
**Regulation:** 38 CFR § 4.117

## What This Condition Is

Non-Hodgkin's lymphoma (NHL) is a cancer that affects the body's lymphatic system, which is part of the hemic and lymphatic systems. The VA rates this condition under Diagnostic Code 7715 in § 4.117.

## Available Rating Level

The VA rates Non-Hodgkin's lymphoma at the following level based on the schedule of ratings:

| Rating | What It Reflects |
| --- | --- |
| **100%** | When there is active disease, during the treatment phase, or with the indolent and non-contiguous phase of low-grade NHL |

## What the VA Looks For

The VA evaluates whether there is active disease, whether the veteran is in a treatment phase, or whether the condition is in the indolent and non-contiguous phase of low-grade NHL.

**How the 100% rating continues and is re-evaluated:**

- A **100 percent evaluation continues beyond the cessation** of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures.
- **Two years after discontinuance** of such treatment, the appropriate disability rating is determined by a **mandatory VA examination**.
- Any reduction in evaluation based upon that or any subsequent examination is subject to the provisions of **§ 3.105(e)**.
- **If there has been no recurrence**, the condition is rated on residuals under the appropriate diagnostic code(s).

---

*This information is drawn from the VA rating schedule for Diagnostic Code 7715 under 38 CFR § 4.117. Individual ratings depend on your specific medical evidence and VA examination.*

Source: https://www.ecfr.gov/current/title-38/section-4.117